Member Info for SocialistB

@dhub

5 pence when we have the all clear to start with clinical trials, sounds a bit conservative to me, if not downright pessimistic:-)

But what do I know, and should I be totally surprised bearing in mind the way this share has acted in the past 6 month or so?

Becoming clinical (especially if fast track), news on partner, news on CBR are all awaited and should be a catalyst.

But again, we are quite a few who have known so for a long time, and it has not happened yet.

"But mark you my words, one day, one day it will happen"

My thread from yesterday gathered a lot of traction, so much so that the original post drowned.

Therefore I've decided to repost it as the news is still out there and that might be worthwhile for any potential new investors looking in over the weekend to be aware of.

I tried to google: Hemogenyx IND application

And I got some of the following results:

https://www.bloomberg.com/press-releases/2023-05-09/hemogenyx-pharmaceuticals-plc-announces-submission-of-ind-for-hemo-car-t

https://www.asktraders.com/analysis/hemogenyx-shares-edged-7-92-higher-on-the-fda-ind-application/

https://www.morningstar.co.uk/uk/news/AN_1683641789718054200/in-brief-hemogenyx-submits-fda-application-for-hemo-car-t-treatment.aspx

https://twitter.com/HemogenyxPharma/status/1329204764853366784

https://shareprices.com/news/in-brief-hemogenyx-submits-fda-application-for-hemo-car-t-treatment-l4y1xy26j9eqefs/

https://www.accesswire.com/753708/Hemogenyx-Pharmaceuticals-PLC-Announces-Submission-of-IND-for-HEMO-CAR-T

https://www.linkedin.com/posts/vladislavsandler_westandwithukraine-activity-6904425722543493120-uuqF

https://cbonds.com/news/2301946/

https://www.marketscreener.com/quote/stock/HEMOGENYX-PHARMACEUTICALS-24857735/news/Hemogenyx-submits-FDA-application-for-Hemo-Car-T-treatment-43790564/

https://www.voxmarkets.co.uk/listings/LON/HEMO/

And last but not least, we got LSE (save the best for last:-)

https://www.lse.co.uk/rns/HEMO/submission-of-ind-for-hemo-car-t-bvkk4erik7cropt.html

In other words, the news about Hemogenyx’s IND application is out there.

So, why the lacklustre rise in the share price?

I still think we need a different kind of investor here. Someone with a different mindset.

I do not expect to see the significant gains that we are all hoping for until it is announced that we are clinical (which could happen as early as next week)

But hey, small 5-10% gains on a daily basis up until then would not be bad either:-)

The news is out there.

I tried to google: Hemogenyx IND application

And I got some of the following results:

https://www.bloomberg.com/press-releases/2023-05-09/hemogenyx-pharmaceuticals-plc-announces-submission-of-ind-for-hemo-car-t

https://www.asktraders.com/analysis/hemogenyx-shares-edged-7-92-higher-on-the-fda-ind-application/

https://www.morningstar.co.uk/uk/news/AN_1683641789718054200/in-brief-hemogenyx-submits-fda-application-for-hemo-car-t-treatment.aspx

https://twitter.com/HemogenyxPharma/status/1329204764853366784

https://shareprices.com/news/in-brief-hemogenyx-submits-fda-application-for-hemo-car-t-treatment-l4y1xy26j9eqefs/

https://www.accesswire.com/753708/Hemogenyx-Pharmaceuticals-PLC-Announces-Submission-of-IND-for-HEMO-CAR-T

https://www.linkedin.com/posts/vladislavsandler_westandwithukraine-activity-6904425722543493120-uuqF

https://cbonds.com/news/2301946/

https://www.marketscreener.com/quote/stock/HEMOGENYX-PHARMACEUTICALS-24857735/news/Hemogenyx-submits-FDA-application-for-Hemo-Car-T-treatment-43790564/

https://www.voxmarkets.co.uk/listings/LON/HEMO/

And last but not least, we got LSE (save the best for last:-)

https://www.lse.co.uk/rns/HEMO/submission-of-ind-for-hemo-car-t-bvkk4erik7cropt.html

In other words, the news about Hemogenyx’s IND application is out there.

So, why the lacklustre rise in the share price?

I still think we need a different kind of investor here. Someone with a different mindset.

I do not expect to see the significant gains that we are all hoping for until it is announced that we are clinical (which could happen as early as next week)

But hey, small 5-10% gains on a daily basis up until then would not be bad either:-)

@Chris0123

I agree with so much of what you're saying.

However, I wonder if it wouldn't give a higher price jump if the following was to happen:

1. Announcement of a significant partner

2. IND approved after 30 days.

3. And even better IND is approved after 10 days only.

4. Fantastic news on CBR.

I think this combination would be a bigger winner, simply because HEMO will than already have shown that they can deliver, are clinical and have the ability to attract a significant partner.

If that does not give the market confidence, then I do not know what it takes.

It has now gone past 0800 and the trading day has started.

But what will it bring?

We now know IND has been submitted and it is going to be interesting to see how many have been waiting on the side lines for this specific moment.

How many are they and what is their purchase capability is.

The last bit is particularly important as that is the driver of the share price.

But another important thing is if they are "JUST" traders or long-term investors as I suspect that will have an effect on sustaining the new share price level.

3 or 4 pence represent a 50 to 100% increase. Many traders would happily sell for less and this could cause a yo-yo effect until we become clinical in less than 30 days or so (and of course we become clinical)

But, I guess that is fair enough, trading this stock has pretty much been the only way to make money in this share in recent years.

However, I do not doubt that we have turned a significant corner. And the era for Long term investors has just kicked off.

Whether you wish to make your money by trading this share or as a long-term shareholder, today the start pistol was fired and I wish you the best of luck.

But let us not forget, hopefully soon there will be a cure for AML and HEMOGENYX will start to save patients' life.

Sorry, but I find it to hard not comment on this following quote:

"Only my opinion but I am not a trader and only know how to play the extremely long waiting game ..."

NO you don't know how to play the waiting game.

Anyone who knows that game, knows it takes patience.

And in my book they do not constantly moan.

But, that is maybe just my opinion.

I do not expect much movement on the information that IND has been submitted.

Reason is that having submitted the IND is no guarantee that is not contested.
I first see the real change coming when we are clinical.

At that point I expect a different kettle of investors to join, some with a lesser risk appetite then those us who is currently here.

Admittedly, I am disappointed that we did not get some money from the grant.
I too believed it was a shoe in at one stage.

But there is without a doubt a reason why we did not get it.

Could it be that HEMO applied but was unsuccessful?

Could it be that HEMO gave up on the application?

IF HEMO gave up, there could be several reasons for this, and just on the top of my head:

They decided to concentrate on IND as it was more cumbersome then anticipated. (But also where the real money is)

To many stipulations and restrictions to comply with if you get the grant.

Maybe they decided, it would be better to first apply in 2023.

Whatever the reason, it would have been nice if it had been explained in last week's annual report.

I don't think HEMOGENYX have applied.

Nothing was mentioned last week in the annual report and considering that it would have had to be applied for no later then a date in October 2022, I would have thought it prudent to inform us if they had applied last year.

I assume they have been too preoccupied with the IND application, which turned out to be a bit more cumbersome then first anticipated.

Maybe, HEMOGENYX will apply before the deadline in 2023, after a successful IND for HEMO CAR-T.

Yes, there was no material new information.

Which is good as in my view it would have to be RNS'ed.

It has been confirmed nothing has failed on the scientific level.
That is awesome itself.

But I really liked this comment "We expect to submit the IND application in the very near future."

VERY NEAR, I take that as mening before the end of May.

And more importantly it should not be rushed.

If there is like really positive news to be announced in the annual report this week, then I expect at least one RNS this week before the annual report is released.

But science cannot be rushed, if it was easy and there was no continuously problems to be solved, then any company could bring at least 4 new products on the market every year.

But science rarely is as straight forward like that.

So, as long as we are not told in the annual report that our candidates have been failures I am quite happy, as all that is needed from my side is further patience.

But admittedly, that is not what I am hoping for this week.

I would like to see the MF of a RNS that shocks the market and creates a stampede.

But that is all up to the markets appetite, should we get positive news.

@Matpr1

Please educate me.

How do you activate the green box system.

I hate to do so, as it is to akin to censorship for my liking.

But I am now to feed up with certain posters, they are simply wasting my time.

Please tell me how to activate the green box system.

Thanks in advance

@Dip666.
I am sorry to hear about your loss.
My deepest condolences to you and your family.

@HedgeHogarth
I saw this post of yours earlier today and it felt me with dread.
I would hate to see you go, as your contributions are much appreciated.

@FIREGUYUK

Thanks for highlighting that post.

And not least HedgeHogarth for writing such a good piece in the first place.

I don't think there is any room for moaning gits today, with such a response from Mr Sandler.

https://twitter.com/vmsandler/with_replies?lang=en-GB

I don't expect any news this week because today is still Passover and tomorrow is Friday, and we rarely get an RNS on a Friday.

Last year the Biodefense grant was announced before Passover, that has not been the case this year. Last year's date fell right in the middle of this year's Passover, so again we might not see or hear anything untill Passover ends (which is today), so again I do not really expect any news until next week.

I must say, that I find it utterly strange that the governor of New York has not clearly stated on what date the "winners" will be announced.

If I remember correctly it was clearly stated that the last day to submit an application was the 6-10-2022.

A good question is if HEMOGENYX felt they were in a good enough position to submit an application by that date.

Another question is if the restrictions about staying in New York for 3 years afterwards with CBR was found to be to restrictive?

Don't get me wrong, I think it would be great to get the grant, but there has been so little communication on the subject that the question hast to be raised: WAS IT EVEN APPLIED FOR?

I hope for no news until next tax year (which is upon us)

I hope for news on the grant first and foremost, weather it is positive or negative.

I would love not to hear that IND has been submitted, I'll much rather just hear out of the blue that we are now clinical.

Or even better yet, that FDA has accelerated the way to becoming clinical, because the groundwork is outstanding.

And then, I would like positive news on CBR.

This is my recipe for an explosive share price rise.

What's your dream scenario / recipe?

@JustHereForHemo

I love your take on a classic Kipling.

Well written for our circumstances.

I think Newmont would want to keep Havieron.

It might not be the biggest of their assets, but it is still a big find.

To me, it simply does not make sense to let a high quality go.

However, that does not mean that they do not make that choice.

And I for one, do hope that if decide to part with Havieron, that we get to be the buyer.

Even if we have to multiply our number of shares with 2, from either today's 5 Billion shares or what ever we end up with after a consolidation.

Part 2

But, let’s say that we don’t get to buy it outright (not because that is my desired scenario, but simply because it does not make sense to me why a 70% owner would let it go)
In a scenario where we do not get 100% of Havieron, but do get some good results from Scallywag, where will we see the biggest increase in mkt cap and thereby the share price.
In other words, which price point is most likely to be multiplied with 3 (just to pick a number)
20 Pence? (end result is in the 60 pence region)
Or
70 Pence? (end result is in the £2.10 region)